First Time Loading...

Valeo Pharma Inc
TSX:VPH

Watchlist Manager
Valeo Pharma Inc Logo
Valeo Pharma Inc
TSX:VPH
Watchlist
Price: 0.105 CAD -8.7% Market Closed
Updated: May 4, 2024

Valeo Pharma Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Valeo Pharma Inc
Revenue Peer Comparison

Comparables:
BHC
TH
K
GUD
EDT
CPH

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Valeo Pharma Inc
TSX:VPH
Revenue
CA$53.9m
CAGR 3-Years
93%
CAGR 5-Years
65%
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Revenue
$8.8B
CAGR 3-Years
3%
CAGR 5-Years
1%
CAGR 10-Years
4%
Theratechnologies Inc
TSX:TH
Revenue
$78.1m
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
27%
K
Knight Therapeutics Inc
TSX:GUD
Revenue
CA$328.2m
CAGR 3-Years
18%
CAGR 5-Years
92%
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Revenue
CA$1.6m
CAGR 3-Years
-9%
CAGR 5-Years
-16%
CAGR 10-Years
-5%
Cipher Pharmaceuticals Inc
TSX:CPH
Revenue
$21.2m
CAGR 3-Years
-1%
CAGR 5-Years
-1%
CAGR 10-Years
-2%

See Also

What is Valeo Pharma Inc's Revenue?
Revenue
53.9m CAD

Based on the financial report for Oct 31, 2023, Valeo Pharma Inc's Revenue amounts to 53.9m CAD.

What is Valeo Pharma Inc's Revenue growth rate?
Revenue CAGR 5Y
65%

Over the last year, the Revenue growth was 94%. The average annual Revenue growth rates for Valeo Pharma Inc have been 93% over the past three years , 65% over the past five years .